Literature DB >> 26254352

Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.

Tadanobu Shimura1, Yuji Toiyama2, Koji Tanaka2, Susumu Saigusa2, Takahito Kitajima2, Satoru Kondo2, Masato Okigami2, Hiromi Yasuda2, Masaki Ohi2, Toshimitsu Araki2, Yasuhiro Inoue2, Keiichi Uchida2, Yasuhiko Mohri2, Masato Kusunoki2.   

Abstract

BACKGROUND: Angiopoietin-like protein-2 (ANGPTL2) mediates chronic inflammation. Tumor cell-derived ANGPTL2 promotes tumor invasion and angiogenesis. ANGPTL2 expression has not been fully investigated in gastric cancer (GC).
MATERIALS AND METHODS: ANGPTL2 expression in 354 patients with GC was assessed by immunohistochemistry (IHC). IHC scores were calculated, and the association of ANGPTL2 with clinicopathological factors and patient outcomes was evaluated.
RESULTS: Immunoreactive ANGPTL2 protein was expressed mainly in GC cell cytoplasm. Kaplan-Meier analysis showed that high expression of ANGPTL2 indicated significantly poorer overall disease-free survival (DFS). Among patients with curatively resected GC, multivariate analysis for DFS revealed that high ANGPTL2 expression (p<0.01), advanced T-stage (p=0.015), lymph node metastasis (p<0.01), and advanced Unio Internationalis Contra Cancrum (UICC) stage (p<0.01) were independent risk factors for poor DFS.
CONCLUSION: High cytoplasmic ANGPTL2 expression in GC tissue was associated with tumor progression, invasion, metastasis, and poor prognosis. ANGPTL2 may be a useful marker for detecting early postoperative recurrence in patients with GC. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  ANGPTL2; Angiopoietin-like protein 2; gastric cancer; immunohistochemistry

Mesh:

Substances:

Year:  2015        PMID: 26254352

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Angiopoietin-like protein 2 is an important facilitator of tumor proliferation, metastasis, angiogenesis and glycolysis in osteosarcoma.

Authors:  Xiuhui Wang; Zhaohui Hu; Zhe Wang; Yin Cui; Xu Cui
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  Lower Methylation of the ANGPTL2 Gene in Leukocytes from Post-Acute Coronary Syndrome Patients.

Authors:  Albert Nguyen; Maya Mamarbachi; Valérie Turcot; Samuel Lessard; Carol Yu; Xiaoyan Luo; Julie Lalongé; Doug Hayami; Mathieu Gayda; Martin Juneau; Nathalie Thorin-Trescases; Guillaume Lettre; Anil Nigam; Eric Thorin
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 3.  High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation.

Authors:  Nathalie Thorin-Trescases; Eric Thorin
Journal:  Oxid Med Cell Longev       Date:  2017-08-24       Impact factor: 6.543

4.  A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.

Authors:  Hui Jiang; Jiming Gu; Jun Du; Xiaowei Qi; Chengjia Qian; Bojian Fei
Journal:  Mol Med Rep       Date:  2019-11-21       Impact factor: 2.952

5.  Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.

Authors:  Long-Qing Li; Liang-Hao Zhang; Yan Zhang; Xin-Chang Lu; Yi Zhang; Yong-Kui Liu; Manhas Abdul Khader; Jia-Zhen Li
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.